Latest News

Nvidia's growth remains remarkable, but every earnings report raises the stakes. See what could strengthen the bull case and which signals investors shouldn't overlook.

Capital discipline and organic growth are funding a $1.1 billion tech bet that advisers say boosts client relationships.

Aerospace and defense company Howmet (NYSE:HWM) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 29.4% year on year to $...

Record operating margins hit 30% as subscription revenue shifts higher, positioning the company to capture ongoing digital transformations in banking.

Shrinking player acquisition costs and expanding state legalization are unlocking margin expansion and a multiyear growth runway.

Construction equipment company Caterpillar (NYSE:CAT) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 17.3% year on year...

HVAC company Trane (NYSE:TT) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 17.7% year on year to $6.76 billion. Its n...

Unlike some funds, this ETF delivers real income.

Homebuilder D.R. Horton (NYSE:DHI) reported calendar Q3 2026 (fiscal Q4 2026) results topping the market’s revenue expectations, but revenue fell by 3.2% yea...

Turbocharger technology company Garrett Motion (NYSE:GTX) met Wall Street’s revenue expectations in Q3 2026, with revenue rising 3.1% year on year to $930 mi...

With just two days to go, these Dividend Kings with attractive yields could be just what you are looking for in October.

The financial stock has generated a total return of 440% during the past decade.

Infrastructure solutions provider Quanta (NYSE:PWR) reported Q3 2026 results topping the market’s revenue expectations, with revenue up 57.4% year on year to...

Haleon (NYSE:HLN) said its third-quarter performance fell below expectations, citing weaker-than-anticipated North American growth, a softer cough, cold and flu season, a Chinese classification issue affecting Centrum, and continued challenging consumer conditions in Europe. Chief Executive Officer

PolyPid (NASDAQ:PYPD) outlined plans to expand its commercial and development strategy through 2030 at an investor day, as the company approaches a November 28, 2026, FDA action date for its D-PLEX100 surgical-site infection prevention product candidate. Chief Executive Officer Dikla Czaczkes Aksel

Befesa (ETR:BFSA) reported higher earnings for the first nine months of 2026 and raised the lower end of its operating adjusted EBITDA guidance, while also outlining an expected benefit from a U.S. Inflation Reduction Act production credit. Management said adjusted EBITDA for the first nine months

Semi-trailer and liquid transportation container manufacturer Wabash (NYSE:WNC) reported Q3 2026 results exceeding the market’s revenue expectations, with re...

Where Solana now has momentum, XRP is struggling.

New stores are outperforming by $200,000 per location while sourcing gains protect margins, creating a dual growth engine.

Global pharmaceutical company Eli Lilly (NYSE:LLY) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 38.6% year on year to...

This fund's multi-targeted approach to dividend stock investing produces a consistently high-quality portfolio.

Pediatric healthcare provider Pediatrix Medical Group (NYSE:MD) reported Q3 2026 results topping the market’s revenue expectations, with revenue up 1.7% year...

Manufacturing services provider Proto Labs (NYSE:PRLB) beat Wall Street’s revenue expectations in Q3 2026, with revenue up 14% year on year to $154.3 million...

Clinical research company Fortrea Holdings (NASDAQ:FTRE) announced better-than-expected revenue in Q3 2026, but revenue fell by 1.4% year on year to $691.5 m...

Alternative asset manager Ares Management (NYSE:ARES) beat Wall Street’s revenue expectations in Q3 2026, with revenue rising 26.1% year on year to $1.43 bil...